Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma AidsDHA:PHARMAID -2.55%73 OCF Margin % is 7.33% as of Mar. 2026, which is 29% below its 10-year median of 10.28. GuruFocus rates DHA:PHARMAID with a GF Score™ of 73/100 and a GF Value™ of BDT758.56 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Pharma Aids ranks better than 64.14% on this metric.
The historical rank and industry rank for Pharma Aids's OCF Margin % or its related term are showing as below:
DHA:PHARMAID'
s OCF Margin % Range Over the Past 10 Years
Min: 2.36 Med: 10.28 Max: 16.6
Current: 12.69
During the past 13 years, the highest OCF Margin % of Pharma Aids was 16.60%. The lowest was 2.36%. And the median was 10.28%.
DHA:PHARMAID's OCF Margin % is ranked better than 64.14% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs DHA:PHARMAID: 12.69
Pharma Aids OCF Margin % Related Terms
Pharma Aids OCF Margin % Historical Data
* Premium members only.
The historical data trend for Pharma Aids's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:PHARMAID vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pharma Aids's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma Aids OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pharma Aids's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Pharma Aids's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma Aids (DHA:PHARMAID) has a OCF Margin % of 7.33% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharma Aids and its competitors. This is 29% below median its historical median of 10.28. Over the past decade, Pharma Aids' OCF Margin % has ranged from 2.36 to 16.60. According to the industry distribution chart, Pharma Aids ranks #293 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 35.9%.
Is Pharma Aids' OCF Margin % too high?
Pharma Aids' current OCF Margin % of 7.33% is 29% below median its 10-year median of 10.28. Over the past 10 years, this metric has ranged from a low of 2.36 to a high of 16.60. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Pharma Aids' value of 7.33% is 25.9% above this industry median. Based on the distribution chart, Pharma Aids ranks #293 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pharma Aids has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Aids' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Pharma Aids ranks #293 out of 817 companies for OCF Margin %. This puts Pharma Aids in the upper half of its industry. The industry median OCF Margin % is 5.82. Pharma Aids' value of 7.33% is 25.9% above this benchmark. Historically, Pharma Aids' own OCF Margin % has ranged from 2.36 to 16.60 over the past decade. While the company's 10-year median is 10.28 vs. the industry median of 5.82, Pharma Aids has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Aids's current OCF Margin % of 7.33% is 25.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharma Aids and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Aids's current OCF Margin % is 7.33%, which is 29% below median its own 10-year median of 10.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Aids stock overvalued right now?
Based on GuruFocus' analysis, Pharma Aids (DHA:PHARMAID) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT758.56, compared to a current price of BDT644.70 — trading 15% below its estimated fair value. The current OCF Margin % is 7.33%, which is 29% below median its 10-year median of 10.28 and 25.9% above the Medical Devices & Instruments industry median of 5.82. Pharma Aids' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Pharma Aids (DHA:PHARMAID), the current OCF Margin % is 7.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma Aids (DHA:PHARMAID) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma Aids stock appears to be undervalued.
The current stock price of BDT644.70 is trading 15% below its estimated GF Value™ of BDT758.56.
GuruFocus considers Pharma Aids to be Modestly Undervalued.
Key valuation signals for DHA:PHARMAID:
OCF Margin %: 7.33% (29% below median its 10-year median of 10.28)
GF Value™: BDT758.56 vs. price of BDT644.70 (15% below fair value)
Industry Position: 25.9% above the Medical Devices & Instruments median (#293 of 817)
No single metric tells the full story. See the DHA:PHARMAID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma Aids Ltd is a Bangladesh-based company engaged in the manufacturing of neutral glass ampoules, USP Type-I. Ampoules are used by pharmaceutical companies for filling liquid injections. The company produces different sizes of ampoules from 1ml to 25ml, in Clear and Amber color, and in Amber color, and of both Open Mouth (Form B and C) and Close Mouth (Form D, Din and Marzocchi type).
73GF Score
Get the complete analysis for DHA:PHARMAID
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:PHARMAID has been successfully added to your 
